Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy-Reference-Cited by-同舟云学术

Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy

Published:2000-11-15 Issue:10 Volume:165 Page:5954-5961
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Stockmeyer Bernhard,Dechant Michael,van Egmond Marjolein,Tutt Alison L.,Sundarapandiyan Karuna,Graziano Robert F.,Repp Roland,Kalden Joachim R.,Gramatzki Martin,Glennie Martin J.,van de Winkel Jan G. J.,Valerius Thomas

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Cancer Undefeated

2. Treatment of Non-Hodgkin's Lymphoma

3. Continuous cultures of fused cells secreting antibody of predefined specificity

4. Monoclonal antibody-based therapies of leukemia and lymphoma

5. CD20: a regulator of cell-cycle progression of B lymphocytes

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains;Cancer Immunology, Immunotherapy;2023-06-20

2. Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective;Cells Tissues Organs;2023-01-04

3. Potentiation of Antitumor Activity by Antibody Drugs and Mushroom-Derived β-Glucans in Natural Killer Cell-Mediated Tumoricidal Activities against Non-Hodgkin's B-Cell Lymphoma;International Journal of Medicinal Mushrooms;2023

4. Tumor-associated neutrophils and neutrophil-targeted cancer therapies;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09

5. Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer;Expert Opinion on Biological Therapy;2022-07-19